- Home
- TARS vs PINC Comparison
TARS vs PINC Comparison
Compare TARS & PINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- PINC
- Stock Information
- Founded
- TARS 2016
- PINC 2013
- Country
- TARS United States
- PINC United States
- Employees
- TARS N/A
- PINC N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- PINC Other Consumer Services
- Sector
- TARS Health Care
- PINC Consumer Discretionary
- Exchange
- TARS Nasdaq
- PINC Nasdaq
- Market Cap
- TARS 1.7B
- PINC 1.8B
- IPO Year
- TARS 2020
- PINC 2013
- Fundamental
- Price
- TARS $57.25
- PINC $25.14
- Analyst Decision
- TARS Strong Buy
- PINC Hold
- Analyst Count
- TARS 7
- PINC 8
- Target Price
- TARS $67.14
- PINC $23.71
- AVG Volume (30 Days)
- TARS 737.4K
- PINC 1.9M
- Earning Date
- TARS 08-06-2025
- PINC 08-19-2025
- Dividend Yield
- TARS N/A
- PINC 3.28%
- EPS Growth
- TARS N/A
- PINC N/A
- EPS
- TARS N/A
- PINC 0.22
- Revenue
- TARS $295,521,000.00
- PINC $1,012,647,000.00
- Revenue This Year
- TARS $122.94
- PINC N/A
- Revenue Next Year
- TARS $44.14
- PINC $1.86
- P/E Ratio
- TARS N/A
- PINC $36.97
- Revenue Growth
- TARS 254.45
- PINC N/A
- 52 Week Low
- TARS $25.14
- PINC $17.23
- 52 Week High
- TARS $57.60
- PINC $27.26
- Technical
- Relative Strength Index (RSI)
- TARS 79.79
- PINC 67.06
- Support Level
- TARS $53.15
- PINC $23.03
- Resistance Level
- TARS $55.17
- PINC $27.26
- Average True Range (ATR)
- TARS 2.03
- PINC 0.93
- MACD
- TARS 0.89
- PINC 0.24
- Stochastic Oscillator
- TARS 97.95
- PINC 63.19
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.